Emergency Visits for Oral Anticoagulant Bleeding
J Gen Intern Med
.
2020 Jan;35(1):371-373.
doi: 10.1007/s11606-019-05391-y.
Epub 2019 Oct 29.
Authors
Andrew I Geller
1
,
Nadine Shehab
2
,
Maribeth C Lovegrove
2
,
Kathleen O Rose
2
3
,
Nina J Weidle
2
4
,
Sandra K Goring
2
3
,
Daniel S Budnitz
2
Affiliations
1
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. ageller@cdc.gov.
2
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
3
Northrup Grumman Corporation, Atlanta, GA, USA.
4
Eagle Global Scientific LLC, Atlanta, GA, USA.
PMID:
31664597
PMCID:
PMC6957602
DOI:
10.1007/s11606-019-05391-y
No abstract available
Publication types
Letter
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
Administration, Oral
Anticoagulants* / adverse effects
Emergency Service, Hospital
Hemorrhage* / chemically induced
Hemorrhage* / epidemiology
Humans
Substances
Anticoagulants